HERBORIUM GROUP Announces Signing the Letter of Intent With China Health Resource Inc. for Possible Acquisition

Herborium Group, Inc., (Pink Sheets: HBRM) www.herborium.com , a Botanical Therapeutics® company, announce today signing the Letter of Intent with China Health Resource, Inc (OTCBB.CHRI) for sales of up 100% interest in Herborium.      

Dr. Agnes Olszewski , Chairman and CEO of Herborium stated: "We are most excited to confirm that we are negotiating with China Health Resource, Inc. for an acquisition of up to 100% interests in Herborium.  Both companies share the mission to bring Botanical Therapeutics®  (natural medicinal products) based on modernized Traditional Chinese Medicine to the mainstream of healthcare.  The world market for botanical drugs is over $500 billion and the time for this move cannot be better as market and regulatory changes in the healthcare sector create rapid growth opportunities. To take advantage of those changes a complex expertise is necessary and Herborium posses such unique expertise.

"By combining Herborium marketing, clinical and regulatory competencies and its proprietary product portfolio with CHRI manufacturing  capabilities, and market access in China we have an opportunity to create a leader in  Botanical Therapeutics® sector. We are looking forward to commence the due diligence  and negotiation process  leading  to successful completion of this transaction," concluded  Dr. Olszewski.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe . For more information, please visit www.herborium.com and www.acnease.com . 

One of our most important responsibilities is to communicate with shareholders in an open and direct manner.  Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends."  We cannot promise future returns.  Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events.  The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com